Mechanisms of Resistance in Multiple Myeloma
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/164_2017_10
Reference221 articles.
1. Alexandrakis MG, Goulidaki N, Pappa CA, Boula A, Psarakis F, Neonakis I, Tsirakis G (2015) Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma. Pathol Oncol Res 21(4):929–934. doi: 10.1007/s12253-015-9921-z
2. Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ et al (2016) T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood 128(13):1688–1700. doi: 10.1182/blood-2016-04-711903
3. Alonso S, Hernandez D, Chang YT, Gocke CD, McCray M, Varadhan R et al (2016) Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. J Clin Invest 126(12):4460–4468. doi: 10.1172/JCI88152
4. Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM et al (2007) Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109(7):2708–2717. doi: 10.1182/blood-2006-07-035857
5. Anderson KC, Carrasco RD (2011) Pathogenesis of myeloma. Annu Rev Pathol 6:249–274. doi: 10.1146/annurev-pathol-011110-130249
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells;Heliyon;2024-06
2. The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients;Biomedicines;2023-11-09
3. Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation;Acta Biochimica et Biophysica Sinica;2023-11-01
4. SOHO State-of-the-Art Updates and Next Questions | BCMA-Directed CAR T-Cells: Early Results and Future Directions;Clinical Lymphoma Myeloma and Leukemia;2023-05
5. Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy;Cancers;2023-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3